TY - JOUR
T1 - Single-cell multi-omic and spatial profiling of esophageal squamous cell carcinoma reveals the immunosuppressive role of GPR116+ pericytes in cancer metastasis
AU - Pei, Xiaoya
AU - Liu, Zhichao
AU - Tang, Lin
AU - Zhang, Junpeng
AU - He, Yan
AU - Zhuang, Xiaowan
AU - Song, Yuxiang
AU - Peng, Shaocong
AU - Zhao, Yahui
AU - Huang, Xuanzhang
AU - Xu, Yiwei
AU - Li, Junyi
AU - Peng, Liang
AU - Shi, Xingyuan
AU - Zhang, Fan
AU - Liu, Chong
AU - He, Mingliang
AU - Dai, Wei
AU - Wu, Liang
AU - Law, Simon
AU - Liu, Jinbao
AU - Wang, Zhenning
AU - Li, Zhigang
AU - Xu, Wenwen
AU - Liu, Zhihua
AU - Li, Bin
PY - 2025/10
Y1 - 2025/10
N2 - Tumor metastasis leads to most cancer deaths. However, how cellular diversity and dynamic cooperation within the tumor microenvironment contribute to metastasis remains poorly understood. Here we leverage single-cell multi-omics (16 samples, 117,169 cells) and spatial transcriptomics (five samples, 195,366 cells) to uncover the cellular and spatial architecture of esophageal squamous cell carcinoma (ESCC), and characterize an immunosuppressive GPR116+ pericyte subset promoting tumor metastasis and immunotherapy resistance. GPR116+ pericyte enrichment is transcriptionally regulated by PRRX1, evidenced by pericyte-specific Prrx1 knockout mice. Mechanistically, GPR116+ pericytes secrete EGFL6 to bind integrin β1 on cancer cells, activating the NF-κB pathway to facilitate metastasis. Serum EGFL6 serves as a noninvasive biomarker for the diagnosis and prognosis of several tumors. Blocking integrin β1 suppresses metastasis and improves immunotherapy response in animal models of ESCC. Collectively, we provide a spatially resolved landscape of the prometastatic tumor microenvironment in ESCC and highlight the biological and clinical importance of GPR116+ pericytes, proposing potential innovative therapeutic strategies for metastatic cancers. © The Author(s), under exclusive licence to Springer Nature America, Inc. 2025.
AB - Tumor metastasis leads to most cancer deaths. However, how cellular diversity and dynamic cooperation within the tumor microenvironment contribute to metastasis remains poorly understood. Here we leverage single-cell multi-omics (16 samples, 117,169 cells) and spatial transcriptomics (five samples, 195,366 cells) to uncover the cellular and spatial architecture of esophageal squamous cell carcinoma (ESCC), and characterize an immunosuppressive GPR116+ pericyte subset promoting tumor metastasis and immunotherapy resistance. GPR116+ pericyte enrichment is transcriptionally regulated by PRRX1, evidenced by pericyte-specific Prrx1 knockout mice. Mechanistically, GPR116+ pericytes secrete EGFL6 to bind integrin β1 on cancer cells, activating the NF-κB pathway to facilitate metastasis. Serum EGFL6 serves as a noninvasive biomarker for the diagnosis and prognosis of several tumors. Blocking integrin β1 suppresses metastasis and improves immunotherapy response in animal models of ESCC. Collectively, we provide a spatially resolved landscape of the prometastatic tumor microenvironment in ESCC and highlight the biological and clinical importance of GPR116+ pericytes, proposing potential innovative therapeutic strategies for metastatic cancers. © The Author(s), under exclusive licence to Springer Nature America, Inc. 2025.
UR - http://www.scopus.com/inward/record.url?scp=105018398353&partnerID=8YFLogxK
UR - https://www.scopus.com/record/pubmetrics.uri?eid=2-s2.0-105018398353&origin=recordpage
U2 - 10.1038/s41588-025-02341-9
DO - 10.1038/s41588-025-02341-9
M3 - RGC 21 - Publication in refereed journal
C2 - 41073785
SN - 1061-4036
VL - 57
SP - 2494
EP - 2508
JO - Nature Genetics
JF - Nature Genetics
IS - 10
ER -